Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio Growth (1y) (2021 - 2024)
Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | 0.27% |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Maravai Lifesciences Holdings | 1.00 Bn | 836.36 Mn | 33.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 147.80% |
| Jun 30, 2023 | -184.44% |
| Mar 31, 2023 | -56.72% |
| Dec 31, 2022 | -82.96% |
| Sep 30, 2022 | -30.91% |
| Jun 30, 2022 | 32.34% |
| Mar 31, 2022 | -60.12% |
| Dec 31, 2021 | -1.40% |
| Sep 30, 2021 | 15,966.18% |
| Jun 30, 2021 | 1,134.75% |